Portfolio

Development

Formulation Technology

Unique, proprietary technologies and expertise provide tools for solving your drug delivery problems and offering you the potential to develop safe, efficacious, and competitive drugs

Controlled release technologies
PROMAXX protein microspheres may be engineered to either release drug immediately (for pulmonary delivery) or offer sustained release (for injectable delivery).

Formulation development expertise
Broad parenteral capabilities including protein stabilization; freeze dry product and process development

Scale up
Expertise includes feasibility and toxicology evaluation, clinical supplies, and commercialization

Clinical

Contract Services

Spectrum of services that provide expertise, capacity, flexibility, and speed to meet your development, clinical and commercial outsourcing needs

Biologic API contract mfg (clinical & commercial)
Biopharmaceuticals including monoclonal antibodies and recombinant proteins in various culture media

Protein expression
Cell banking
Protein design
Cell line optimization

Process development
Molecular biology
Purification
Characterization
Yield improvement

Finished product dosage form (clinical & commercial)

Sterile crystallization (cytotoxics)

Form/Fill/Finish services
Syringe/vial/cartridge filling
Lyophilization (including cytotoxics)
Aseptic powder filling (cytotoxics only)
Aseptic liquid filling

Customized inspection/labeling/packaging
Automated kitting

Clinical supply services
Blinded labeling/packaging

Commercialization

Enhanced Packaging

Unique, proprietary packaging and global franchise to differentiate your drug

Over 1 billion enhanced packaging products sold
Aseptic processing expertise – industry leader using barrier isolator technology for parenterals
The only manufacturer of frozen, aseptically filled flexible containers for pharma products
Baxter operates in more than 100 countries worldwide